In addition, using the Down syndrome model, a recent study found that B2M acted as a neuronal NMDA receptor antagonist to impair neuronal synaptic function and cognitive ability in mice independently of the MHC-I molecule (Gao et al. 2023). This evidence concerns the gene B2M and Down syndrome.